Skip links and keyboard navigation

Contact us

Get in touch with the QoVAX Program team by:

Oversight of the QoVAX Program

Our work is guided by the National Statement on Ethical Conduct in Human Research (2018).

Research involving people requires ethics review and approval by a human research ethics committee (or HREC).

The QoVAX Program Statewide Study has been approved by the Royal Brisbane and Women’s Hospital Human Research Ethics Committee (HREC/2021/QRBW/81904).

The QoVAX Program Pilot Booster Study has been approved by the Royal Brisbane and Women’s Hospital Human Research Ethics Committee (HREC/2021/QRBW/74899).

The QoVAX Program Pilot Study has been approved by the Royal Brisbane and Women’s Hospital Human Research Ethics Committee (HREC/2021/QRBW/74899).

The QoVAX Program Mixed Dose 1 and 2 Study has been approved by the Royal Brisbane and Women’s Hospital Human Research Ethics Committee (HREC/2021/QRBW/79314).

Ethics enquiries

Royal Brisbane and Women’s Hospital HREC
HREC Executive Officer  
Call: (07) 3647 1007  
Email: RBWH-Ethics@health.qld.gov.au

Complaints

MNHHS Research Governance Manager  
Call: (07) 3647 9550  
Email: MNHHS-RGO@health.qld.gov.au

Last updated: 24 August 2022